Published 2020 | Version v1
Publication

International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

Description

Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma under dialysis are limited due to patient exclusion from clinical trials. Thus, we aimed to evaluate the rate, prevalence, tolerability, and outcome of sorafenib in this population.

Additional details

Created:
April 14, 2023
Modified:
November 30, 2023